Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

5 Most popular Pharmacovigilance blog posts of 2016

Posted on January 26th, 2017 by in Pharmacovigilance

The most-read pharmacovigilance posts of the year really demonstrate the breadth and depth of issues that professionals in this area are dealing with. In these blogs, authors tackled subjects as varied as leadership needs, compliance metrics, the role of scientific literature in identifying adverse events (more…)

Top questions on the minds of QPPV

Posted on December 21st, 2016 by in Pharmacovigilance

The 2016 Pharmacovigilance Days (PHV Day 2016) kicked off in early April 2016 in Berlin, Germany. Afterwards, the tour continued to Amsterdam, London, Copenhagen, Rome and Paris in October and November. With the objective of bringing together safety experts from the pharmaceutical and healthcare industry (more…)

The Intersection of Pharma and Tech: Digital Pharma

Posted on October 19th, 2016 by in Pharma R&D

For years, the pharmaceutical or biopharma industry and the information technology (IT) sector seemed to be more or less separate entities. This has certainly changed in more recent times. (more…)

The New Clinical Trial Directive, Low Risk Intervention Clinical Trials and Pharmacovigilance Reporting Adjustments

Posted on October 3rd, 2016 by in Pharmacovigilance

The new Clinical Trial Directive (EU 536/2014), is applicable since May 2016 with a transition period of three years (May 2019) for CT applications submitted before that date. (more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5